Whitehawk Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -80.7% | -80.7% | -69.7% |
| FY2022 | -38.2% | -38.2% | -32.8% |
| FY2023 | -62.5% | -62.5% | -49.7% |
| FY2024 | -121.4% | -121.4% | -90.6% |
| FY2025 | -15.1% | -15.1% | -13.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -80.7% | -80.7% | -69.7% |
| FY2022 | -38.2% | -38.2% | -32.8% |
| FY2023 | -62.5% | -62.5% | -49.7% |
| FY2024 | -121.4% | -121.4% | -90.6% |
| FY2025 | -15.1% | -15.1% | -13.7% |